Company: CWAN
Filing Date: 2025-03-06
Form Type: S-4/A
Source: 0001193125-25-048570
Chunk: 239

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-06
Form: S-4/A
Chunk 239
---
, net of current portion to Operating lease liability, less 
 current portion.                                                                                                |

| k. | Represents the reclassification of Total revenues to Revenues. Further revenue disaggregation not required due 
 to insignificance of Managed Services and Other.                                                               |

| l. | Represents the reclassification of Total cost of revenues to Cost of revenue. Further revenue disaggregation 
 not required due to insignificance of Managed services and Other.                                            |

| m. | Represents the reclassification of Technology and development expenses to Research and development expenses. |

| n. | Represents the reclassification of Interest income, net to Interest (income) expense, net. |

| o. | Represents the reclassification of TRA expense from Other (income) expense, net to Tax receivable agreement 
 expense.                                                                                                    |

| p. | Represents the reclassification of Other expense, net to Other (income) expense, net. |

| q. | Represents the reclassification of Income taxes to Provision for (benefit from) income taxes. |

156

| r. | Represents the reallocation of certain operating expenses among Cost of revenue (“COR”),                                                                  
 Research and development (“R&D”), Sales and marketing (“S&M”), and General & administrative (“G&A”) expenses to align to Clearwater’s policy, as follows: |

|                                                              |     | For the Year ended December 31, 2024 |        |   |     |     |       |     |     |       |     |     |         |   |
|:-------------------------------------------------------------|:----|:-------------------------------------|-------:|:--|:----|:----|------:|:----|:----|------:|:----|:----|--------:|:--|
| (in thousands)                                               |     | COR                                  |        |   |     | R&D |       |     | S&M |       |     | G&A |         |   |
| Facilities expenses                                          |     |                                      |        |   |     |     |       |     |     |       |     |     |         |   |
| Reversal of Enfusion’s historical facilities expenses        |     |                                      | (2,390 | ) |     |     |     — |     |     |     — |     |     |  (2,944 | ) |
| Facilities expenses allocated based on Clearwater’s policy   |     |                                      |  3,127 |   |     |     | 1,130 |     |